3.77 Reporting of Race in US FDA Registration Trials with Dr. Mark Lythgoe
Today we talk with Dr. Mark Lythgoe, a Clinical R…
Plenary Session - inactive due to federal service · Plenary Session - inactive due to federal service
May 17, 202125m 54sExplicit
Audio is streamed directly from the publisher (feeds.soundcloud.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Today we talk with Dr. Mark Lythgoe, a Clinical Research Fellow at Imperial College London, on his new paper titled "Race reporting and diversity in US food and drug administration (FDA) registration trials for prostate cancer; 2006-2020", out now in Prostate Cancer and Prostatic Diseases.
Race Reporting: doi.org/10.1038/s41391-021-00361-0
Back us on Patreon! www.patreon.com/plenarysession
Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew
Topics
medicineoncologyhealthpolicy